Low handgrip strength was independently associated with increased mortality in both men (HR 2.09; 95% CI 1.39-3.17) and women (HR 2.14; 95% CI 1.16-4.01) with liver cirrhosis.
Cohort (n=563)
No
Effect estimate: HR 2.09 (95% CI 1.39-3.17)
p-value: p=<0.001
AIM: Handgrip strength (HGS) is a marker of sarcopenia and has been used to stratify an individual's risk of death. We aimed to assess the prognostic significance of HGS in patients with liver cirrhosis. METHODS: In this retrospective study, we collated data of 563 consecutive patients admitted to our hospital with cirrhosis (375 men). A dynamometer was used to measure HGS. Body composition (including skeletal muscle and adipose tissue volumes) was estimated using computed tomography. Predictors of mortality were identified using sex-stratified multivariate analyses. RESULTS: After adjustments for age, cirrhosis etiology, Child-Pugh score, and other confounding variables, HGS, but not body composition, was independently associated with mortality in male patients (hazard ratio HR, 0.96; 95% confidence interval CI, 0.94-0.99; P < 0.01) and female patients (HR, 0.91; 95% CI, 0.84-0.99; P = 0.02). Men with low HGS (<30 kg) had a higher risk of mortality (HR, 2.09; 95% CI, 1.39-3.17; P < 0.001), as did women with low (<15 kg) HGS (HR, 2.14; 95% CI, 1.16-4.01; P = 0.02). We could stratify the sex-specific risk of mortality in cirrhotic patients using HGS, regardless of coexistent hepatocellular carcinoma and the Child-Pugh class. CONCLUSIONS: Reduced HGS, rather than skeletal muscle and adipose tissue volumes, is associated with an increased risk of mortality in patients of both sexes with liver cirrhosis. Measurement of HGS is a simple, cost-effective, and appropriate bedside assessment for the prediction of survival in patients with cirrhosis.
Hanai et al. (Tue,) conducted a cohort in Liver cirrhosis (n=563). Low handgrip strength vs. Normal handgrip strength was evaluated on Mortality (HR 2.09, 95% CI 1.39-3.17, p=<0.001). Low handgrip strength was independently associated with increased mortality in both men (HR 2.09; 95% CI 1.39-3.17) and women (HR 2.14; 95% CI 1.16-4.01) with liver cirrhosis.